Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma × Mind-Body Therapies × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 2 Glioblastoma 2 Brain Neoplasms 2 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Meningioma 1 Medulloblastoma 1 Lymphoma 1 Gliosarcoma 1 Female Reproductive Cancer 1 Fallopian Tube Neoplasms 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

Cyclophosphamide 24 Rituximab 16 fludarabine phosphate 13 Radiotherapy 12 Vincristine 10 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 Filgrastim 10 Cytarabine 10 Methotrexate 9 Exercise 9 Doxorubicin 9 Cyclosporine 9 Busulfan 8 Antilymphocyte Serum 8 Mycophenolic Acid 7 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 6 Surveys and Questionnaires 6 Prednisone 6 Prednisolone 6 Methods 6 Etoposide 6 Educational Status 6 Early Intervention, Educational 6 Blood Specimen Collection 6 Palliative Care 5 Leucovorin 5 fludarabine 4 Geriatric Assessment 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05982223 2023-08-08

Integrative Medicine in Lymphoma Survivors

Bnai Zion Medical Center

Phase NA Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡